Literature DB >> 22533676

Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer.

Ahmet Ilter Guney1, Deniz Sevinc Ergec, Hasan Huseyin Tavukcu, Gulsah Koc, Deniz Kirac, Korkut Ulucan, Dilara Javadova, Levent Turkeri.   

Abstract

BACKGROUND: Mitochondrial DNA (mtDNA) mutations have been recently described in various tumors; however, data focusing on bladder cancer are scarce. To understand the significance of mtDNA mutations in bladder cancer development, we investigated the mtDNA alterations in bladder cancer cases.
METHODS: We studied the mtDNA in 38 bladder tumors and 21 microdissected normal bladder tissue samples. Mitochondrial genes ATPase6, CytB, ND1, and D310 region were amplified by polymerase chain reaction and then sequenced.
RESULTS: We detected 40 mutations in our patient population. Our findings indicate that G8697A, G14905A, C15452A, and A15607G mutations are frequent in bladder cancers (p<0.05). In addition, the incidence of A3480G, T4216C, T14798C, and G9055A mutations were higher in patients with bladder tumors.
CONCLUSIONS: In conclusion, the high incidence of mtDNA mutations in bladder cancer suggests that mitochondria could play an important role in carcinogenesis and mtDNA could be a valuable marker for early bladder cancer diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22533676     DOI: 10.1089/gtmb.2011.0227

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

1.  Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis.

Authors:  Edoardo Errichiello; Antonella Balsamo; Marianna Cerni; Tiziana Venesio
Journal:  J Mol Med (Berl)       Date:  2015-07-03       Impact factor: 4.599

2.  Investigation of the association between mitochondrial DNA and p53 gene mutations in transitional cell carcinoma of the bladder.

Authors:  Tuba Avcilar; Deniz Kirac; Deniz Ergec; Gulsah Koc; Korkut Ulucan; Zehra Kaya; Elif Cigdem Kaspar; Levent Turkeri; Ahmet Ilter Guney
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

3.  Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3.

Authors:  Tomoyoshi Komiyama; Atsushi Ogura; Takatsugu Hirokawa; Miao Zhijing; Hiroshi Kamiguchi; Satomi Asai; Hayato Miyachi; Hiroyuki Kobayashi
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

4.  The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients.

Authors:  Massoud Ghaffarpour; Reza Mahdian; Forouzandeh Fereidooni; Behnam Kamalidehghan; Nasrin Moazami; Massoud Houshmand
Journal:  Cancer Cell Int       Date:  2014-03-03       Impact factor: 5.722

5.  Tissue-specific mitochondrial heteroplasmy at position 16,093 within the same individual.

Authors:  Kaarel Krjutškov; Marina Koltšina; Kelli Grand; Urmo Võsa; Martin Sauk; Neeme Tõnisson; Andres Salumets
Journal:  Curr Genet       Date:  2013-07-11       Impact factor: 3.886

Review 6.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

Review 7.  The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis.

Authors:  Silvana Valdebenito; Emil Lou; John Baldoni; George Okafo; Eliseo Eugenin
Journal:  Int J Mol Sci       Date:  2018-04-24       Impact factor: 5.923

8.  Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.

Authors:  K Németh; O Darvasi; I Likó; N Szücs; S Czirják; L Reiniger; B Szabó; P A Kurucz; L Krokker; P Igaz; A Patócs; H Butz
Journal:  J Endocrinol Invest       Date:  2019-01-25       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.